Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Multicenter cooperation--basis of progression in leukemia treatment].
Savchenko VG, Parovichnikova EN, Mendeleeva LP, Kliasova GA, Kulikov SM, Isaev VG, Liubimova LS, Kravchenko SK, Khoroshko ND, Konstantinova TS, Rossiev VA, Rukavitsyn OA, Shamanskiĭ SV, Zagoskina TP, Lapin VA, Rotanova MN, Anchukova LV, Filatov LB, Ziuzgin IS, Rekhtman GB, Moskov VI, Sokolova IV, Kaplanov KD, Samoĭlova OS, Tumakov VA, Obidina NA, Maliutina GI, Dunaev IuA, Pristupa AS, Strokin AA, Khlevnaia NV, Pospelova TN, Kaporskaia TS, Khuazheva NK, Gavrilova LV, Men'shakova SN, Pilipenko GV, Domnikova NP, Medvedeva LI, Sviridova EI, Maksimov AV, Korobkin AV. Savchenko VG, et al. Among authors: korobkin av. Ter Arkh. 2005;77(7):5-11. Ter Arkh. 2005. PMID: 16116901 Russian. No abstract available.
[The results of a multicenter randomized trial on the treatment of acute myeloid leukemia of adults].
Parovichnikova EN, Savchenko VG, Isaev VG, Sokolov AN, Kulikov SM, Kliasova GA, Ryzhko VV, Kravchenko SK, Khoroshko ND, Konstantinova TS, Zagoskina TP, Ziuzgin IS, Rekhtman GB, Moskov VI, Sokolova IV, Anchukova LV, Lapin VA, Loginov AB, Tumakov VA, Korobkin AV, Miliutina GI, Samoĭlova OS, Mal'tsev VI, Pristupa AS, Men'shakova SN, Domnikova NP, Gavrilova LV, Obidina NA, Porokhina OV, Kaplanov KD, Medvedeva LI, Khuazheva NK, Pilipenko GI, Golubeva ME, Maksimov AG, Ploskikh MA, Khlevnaia NV. Parovichnikova EN, et al. Among authors: korobkin av. Ter Arkh. 2007;79(7):14-9. Ter Arkh. 2007. PMID: 17802784 Clinical Trial. Russian.
[Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies].
Parovichnikova EN, Savchenko VG, Kliasova GA, Isaev VG, Sokolov AN, Kulikov SM, Ustinova EN, Gribanova EO, Ryzhko VV, Khoroshko ND, Kravchenko SK, Galstian GM, Konstantinova TS, Zagoskina TP, Ziuzgin IS, Kaplanov KD, Moskov VI, Sokolova IV, Anchukova LV, Lapin VA, Loginov AB, Tumakov VA, Korobkin AV, Miliutina GI, Samoĭlova OS, Tikunova TS, Pristupa AS, Kondakova EV, Domnikova NP, Gavrilova LV, Obidina NA, Porokhina OV, Rekhtman GB, Mashchuk VN, Khuazheva NK, Kaporskaia TS, Golubeva ME, Maksimov AG, Ploskikh MA, Men'shakova SN, Mal'tsev VI, Rossiev VA, Pilipenko GI. Parovichnikova EN, et al. Among authors: korobkin av. Ter Arkh. 2010;82(7):5-11. Ter Arkh. 2010. PMID: 20853602 Clinical Trial. Russian.
[Treatment for acute promyelocytic leukemia during pregnancy].
Troitskaia VV, Parovichnikova EN, Sokolov AN, Kokhno AV, Makhinia SA, Galstian GM, Konstantinova TS, Mazurok LA, Goriachok IG, Korobkin AV, Liubshenko MA, Latyshkevich OA, Zvereva AV, Kurtser MA, Savchenko VG. Troitskaia VV, et al. Among authors: korobkin av. Ter Arkh. 2013;85(10):56-63. Ter Arkh. 2013. PMID: 24437219 Russian.
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial].
Kulagin AD, Bakirov BA, Davydkin IL, Elykomov IV, Konstantinova TS, Korobkin AV, Kosinova MV, Mazurov VI, Minaeva NV, Proidakov AV, Ptushkin VV, Shatokhin YV, Lin'kova YN, Zinkina-Orikhan AV, Morozova MA. Kulagin AD, et al. Among authors: korobkin av. Ter Arkh. 2021 Nov 15;93(11):1340-1348. doi: 10.26442/00403660.2021.11.201226. Ter Arkh. 2021. PMID: 36286657 Clinical Trial. Russian.
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.
Kulagin AD, Ptushkin VV, Lukina EA, Davydkin IL, Korobkin AV, Shamrai VS, Konstantinova TS, Kaporskaya TS, Mitina TA, Ksenzova TI, Zuev EV, Markova OA, Gapchenko EV, Kudlay DA. Kulagin AD, et al. Among authors: korobkin av. Ann Hematol. 2021 Nov;100(11):2689-2698. doi: 10.1007/s00277-021-04624-7. Epub 2021 Aug 16. Ann Hematol. 2021. PMID: 34398258 Free PMC article. Clinical Trial.